PhD: University of Wolverhampton, Wolverhampton, UK, 2000
Pluripotent stem cell biology; disease modeling with human iPSCs; hPSC-derived organoids
Large-scale and innervated functional human gut tissues for transplantation via transient spheroid confinement. Nature Biomedical Engineering. 2026; 10(10):2077-2093.
Frequency of ZFHX3-Mediated Spinocerebellar Ataxia 4 in a US Undiagnosed Ataxia Cohort. Movement Disorders. 2026; 41(9):2476-2489.
DNASE1L3 Deficiency With Novel Missense Variant: Enzymatic and Plasma Fragmentomic Evidence of Pathogenicity and Partial Response to JAK Blockade. ACR Open Rheumatology. 2026; 8(2):e70184.
SUN-056 The National Biorepository and Resource for Pituitary Neuroendocrine Tumor Translational Research (BioPitNeT) Journal of the Endocrine Society. 2025; 9(Supplement_1):bvaf149.1641.
Integrating collecting systems in human kidney organoids through fusion of distal nephron to ureteric bud. Cell Stem Cell. 2025; 32(7):1055-1070.e8.
Human pluripotent stem cell-derived organoids repair damaged bowel in vivo. Cell Stem Cell. 2024; 31(10):1513-1523.e7.
Protocol for establishing inducible CRISPR interference system for multiple-gene silencing in human pluripotent stem cells. STAR Protocols. 2024; 5(3):103221.
Protocol for establishing inducible CRISPRd system for blocking transcription factor-binding sites in human pluripotent stem cells. STAR Protocols. 2024; 5(3):103233.
Pioneer and PRDM transcription factors coordinate bivalent epigenetic states to safeguard cell fate. Molecular Cell. 2024; 84(3):476-489.e10.
Christopher N. Mayhew, PhD7/28/2022